Jennifer L Steshyn,
Research Coordinator
Department:
MD-NEUROMUSCULAR NEUROLOGY
Business Email:
jsteshyn@ufl.edu
On This Page
Grants
-
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Antisense Oligonucleotide AMX0114 Administered to Adult Participants with Amyotrophic Lateral Sclerosis
Active
- Role:
- Other
- Funding:
- AMYLYX PHARMACEUTICALS
-
Platform Trial for the Treatment of Amyotrophic Lateral Sclerosis (A LS): A perpetual multi-center, multi-regimen, clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS
Active
- Role:
- Other
- Funding:
- MASSACHUSETTS GENERAL HOSPITAL
Contact Details
Emails:
- Business:
- jsteshyn@ufl.edu
Addresses: